Skip to main content

Ultragenyx Pharmaceutical Inc 10-Q for FY2026 Q2

Ultragenyx Pharmaceutical Inc. (RARE)

10-Q 2026-08-05 For: 2026-06-30
View Original
Added on August 05, 2026

About this 10-Q

Ultragenyx Pharmaceutical Inc filed this 10-Q on August 5, 2026, covering the quarter ended June 30, 2026 (FY2026 Q2).

Headline figures

Quarter ended June 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$214M
up 28.1% from $167M a year earlier
Net loss
$92M
compared with a net loss of $115M a year earlier
Diluted EPS
-$0.90
compared with -$1.17 a year earlier